This study seems to have been funded by Sintx, then Amedica, and Biomet before it merged with Zimmer in 2007
Study was from 2007, merger took place in 2015, just to clarify.
So now you're saying Sonny's a crook?
If Sonnys a crook then you all have been helping him. I should have added that this couldnt happen if Zimmer Biomet didnt want it to. An official collaboration would instantly stop this.
The fact remains that Zimmer was purposefully removed from the 2013 IPO paperwork in regards to at least Dr Link indicating a plan was in place before Sonny became Chairman/CEO.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Extra information on the status of a Si3n4 based hip implant:
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies